AP1 Regulation of Proliferation and Initiation of Apoptosis in Erythropoietin-dependent Erythroid Cells

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1998 Jun 25

PMID 9632752

Citations 28

Authors

A Wickrema

M J Birrer

S T Sawyer

Affiliations

Soon will be listed here.

Abstract

The transcription factor AP1 has been implicated in the induction of apoptosis in cells in response to stress factors and growth factor withdrawal. We report here that AP1 is necessary for the induction of apoptosis following hormone withdrawal in the erythropoietin (EPO)-dependent erythroid cell line HCD57. AP1 DNA binding activity increased upon withdrawal of HCD57 cells from EPO. A dominant negative AP1 mutant rendered these cells resistant to apoptosis induced by EPO withdrawal and blocked the downregulation of Bcl-XL. JunB is a major binding protein in the AP1 complex observed upon EPO withdrawal; JunB but not c-Jun was present in the AP1 complex 3 h after EPO withdrawal in HCD57 cells, with a concurrent increase in junB message and protein. Furthermore, analysis of AP1 DNA binding activity in an apoptosis-resistant subclone of HCD57 revealed a lack of induction in AP1 DNA binding activity and no change in junB mRNA levels upon EPO withdrawal. In addition, we determined that c-Jun and AP1 activities correlated with EPO-induced proliferation and/or protection from apoptosis. AP1 DNA binding activity increased over the first 3 h following EPO stimulation of HCD57 cells, and suppression of AP1 activity partially inhibited EPO-induced proliferation. c-Jun but not JunB was present in the AP1 complex 3 h after EPO addition. These results implicate AP1 in the regulation of proliferation and survival of erythroid cells and suggest that different AP1 factors may play distinct roles in both triggering apoptosis (JunB) and protecting erythroid cells from apoptosis (c-Jun).

Citing Articles

Retinoic acid receptor regulation of decision-making for cell differentiation.

Brown G Front Cell Dev Biol. 2023; 11:1182204.

PMID: 37082619 PMC: 10110968. DOI: 10.3389/fcell.2023.1182204.

Transcription Factors in the Development and Pro-Allergic Function of Mast Cells.

Srivastava M, Kaplan M Front Allergy. 2022; 2:679121.

PMID: 35387064 PMC: 8974754. DOI: 10.3389/falgy.2021.679121.

Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.

Hwang W, Park W, Suh D, Kim K, Kim Y, No J Int J Mol Sci. 2021; 22(19).

PMID: 34638596 PMC: 8508876. DOI: 10.3390/ijms221910255.

Short-term transcriptomic response to plasma membrane injury.

Hager S, Dias C, Sonder S, Olsen A, da Piedade I, Heitmann A Sci Rep. 2021; 11(1):19141.

PMID: 34580330 PMC: 8476590. DOI: 10.1038/s41598-021-98420-y.

Bcl-xL: A Focus on Melanoma Pathobiology.

Luciano A, Perez-Oliva A, Mulero V, Del Bufalo D Int J Mol Sci. 2021; 22(5).

PMID: 33803452 PMC: 7967179. DOI: 10.3390/ijms22052777.

References

Koury M, Bondurant M . The molecular mechanism of erythropoietin action. Eur J Biochem. 1992; 210(3):649-63. DOI: 10.1111/j.1432-1033.1992.tb17466.x. View

Deng T, Karin M . JunB differs from c-Jun in its DNA-binding and dimerization domains, and represses c-Jun by formation of inactive heterodimers. Genes Dev. 1993; 7(3):479-90. DOI: 10.1101/gad.7.3.479. View

Brown P, Alani R, Preis L, Szabo E, Birrer M . Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene. 1993; 8(4):877-86. View

Damen J, Mui A, Puil L, Pawson T, Krystal G . Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood. 1993; 81(12):3204-10. View

Hsu J, Cressman D, TAUB R . Promoter-specific trans-activation and inhibition mediated by JunB. Cancer Res. 1993; 53(16):3789-94. View

Witthuhn B, Quelle F, Silvennoinen O, Yi T, Tang B, Miura O . JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 1993; 74(2):227-36. DOI: 10.1016/0092-8674(93)90414-l. View

Damen J, Liu L, CUTLER R, Krystal G . Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood. 1993; 82(8):2296-303. View

Kelley L, Koury M, Bondurant M, Koury S, Sawyer S, Wickrema A . Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood. 1993; 82(8):2340-52. View

He T, Zhuang H, Jiang N, Waterfield M, Wojchowski D . Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood. 1993; 82(12):3530-8. View

10.

Brown P, Chen T, Birrer M . Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene. 1994; 9(3):791-9. View

11.

Domann F, LEVY J, Birrer M, Bowden G . Stable expression of a c-JUN deletion mutant in two malignant mouse epidermal cell lines blocks tumor formation in nude mice. Cell Growth Differ. 1994; 5(1):9-16. View

12.

Francastel C, Groisman R, Pfarr C, Robert-Lezenes J . Antisense c-jun overcomes a differentiation block in a murine erythroleukemia cell line. Oncogene. 1994; 9(7):1957-64. View

13.

Todokoro K, Sugiyama M, Nishida E, Nakaya K . Activation of mitogen-activated protein kinase cascade through erythropoietin receptor. Biochem Biophys Res Commun. 1994; 203(3):1912-9. DOI: 10.1006/bbrc.1994.2411. View

14.

Zhuang H, Patel S, He T, Niu Z, Wojchowski D . Dominant negative effects of a carboxy-truncated Jak2 mutant on Epo-induced proliferation and Jak2 activation. Biochem Biophys Res Commun. 1994; 204(1):278-83. DOI: 10.1006/bbrc.1994.2456. View

15.

Miura Y, Miura O, Ihle J, Aoki N . Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J Biol Chem. 1994; 269(47):29962-9. View

16.

Miura O, Miura Y, Nakamura N, Quelle F, Witthuhn B, Ihle J . Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor. Blood. 1994; 84(12):4135-41. View

17.

Sawyer S, Penta K . Erythropoietin cell biology. Hematol Oncol Clin North Am. 1994; 8(5):895-911. View

18.

Wakao H, Gouilleux F, Groner B . Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J. 1995; 14(4):854-5. PMC: 398153. DOI: 10.1002/j.1460-2075.1995.tb07064.x. View

19.

Tauchi T, Feng G, Shen R, Hoatlin M, Bagby Jr G, Kabat D . Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem. 1995; 270(10):5631-5. DOI: 10.1074/jbc.270.10.5631. View

20.

Schlingensiepen R, Terlau H, Brysch W, Schlingensiepen K . Differential expression of c-jun, junB and junD in rat hippocampal slices. Neuroreport. 1994; 6(1):101-4. DOI: 10.1097/00001756-199412300-00027. View